Literature DB >> 15142709

Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.

E Senol1.   

Abstract

Stenotrophomonas maltophilia is a significant pathogen that primarily affects patients with co-morbid illnesses, usually malignancies, who have been hospitalized for prolonged periods and received broad-spectrum antibiotic therapy. The organism has been associated with an expanding spectrum of clinical manifestations associated with high case to fatality ratios. Therapy of these infections presents a significant challenge both for the clinician and the microbiologists because of its high-level antibiotic resistance to most of the currently used agents and methodological difficulties in susceptibility testing with this organism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142709     DOI: 10.1016/j.jhin.2004.01.033

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  33 in total

1.  Molecular detection of transcriptionally active bacteria from failed prosthetic hip joints removed during revision arthroplasty.

Authors:  M P Riggio; Kate E Dempsey; Allan Lennon; David Allan; Gordon Ramage; Jeremy Bagg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-08       Impact factor: 3.267

2.  Isolation of multidrug-resistant Stenotrophomonas maltophilia from cultured yellowtail (Seriola quinqueradiata) from a marine fish farm.

Authors:  Manabu Furushita; Akira Okamoto; Toshimichi Maeda; Michio Ohta; Tsuneo Shiba
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

3.  Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units?

Authors:  E Meyer; F Schwab; P Gastmeier; H Rüden; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

4.  Isolation of new Stenotrophomonas bacteriophages and genomic characterization of temperate phage S1.

Authors:  Pilar García; Cristina Monjardín; Rebeca Martín; Carmen Madera; Nora Soberón; Eva Garcia; Alvaro Meana; Juan E Suárez
Journal:  Appl Environ Microbiol       Date:  2008-10-24       Impact factor: 4.792

5.  Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates.

Authors:  Renjan Thomas; Rukman Awang Hamat; Vasanthakumari Neela
Journal:  Virulence       Date:  2014-01-21       Impact factor: 5.882

6.  Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis.

Authors:  Takashi Obata; Yoshiyuki Goto; Jun Kunisawa; Shintaro Sato; Mitsuo Sakamoto; Hiromi Setoyama; Takahiro Matsuki; Kazuhiko Nonaka; Naoko Shibata; Masashi Gohda; Yuki Kagiyama; Tomonori Nochi; Yoshikazu Yuki; Yoshiko Fukuyama; Akira Mukai; Shinichiro Shinzaki; Kohtaro Fujihashi; Chihiro Sasakawa; Hideki Iijima; Masatoshi Goto; Yoshinori Umesaki; Yoshimi Benno; Hiroshi Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-01       Impact factor: 11.205

7.  Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.

Authors:  B Saugel; K Eschermann; R Hoffmann; A Hapfelmeier; C Schultheiss; V Phillip; F Eyer; K-L Laugwitz; R M Schmid; W Huber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-07       Impact factor: 3.267

8.  The human oral microbiome.

Authors:  Floyd E Dewhirst; Tuste Chen; Jacques Izard; Bruce J Paster; Anne C R Tanner; Wen-Han Yu; Abirami Lakshmanan; William G Wade
Journal:  J Bacteriol       Date:  2010-07-23       Impact factor: 3.490

9.  Cluster of Stenotrophomonas maltophilia endocarditis after prosthetic valve replacement.

Authors:  Manica Müller-Premru; Tone Gabrijelcic; Borut Gersak; Jana Kolman; Natasa Svent-Kucina; Vesna Spik; Tatjana Lejko-Zupanc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

10.  Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.

Authors:  Arianna Pompilio; Valentina Crocetta; Pamela Confalone; Mauro Nicoletti; Andrea Petrucca; Simone Guarnieri; Ersilia Fiscarelli; Vincenzo Savini; Raffaele Piccolomini; Giovanni Di Bonaventura
Journal:  BMC Microbiol       Date:  2010-04-07       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.